Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)
Public ClinicalTrials.gov record NCT01109121. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Parallel Group Study to Evaluate the Safety and Efficacy of Tranilast in Combination With Allopurinol in Patients With Moderate to Severe Gout (TAnGO)
Study identification
- NCT ID
- NCT01109121
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Nuon Therapeutics, Inc.
- Industry
- Enrollment
- 112 participants
Conditions and interventions
Conditions
Interventions
- Combination 400 Drug
- Allopurinol Drug
- Combination 600 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2010
- Primary completion
- Nov 30, 2010
- Completion
- Dec 31, 2010
- Last update posted
- Jan 5, 2011
2010 – 2011
United States locations
- U.S. sites
- 24
- U.S. states
- 20
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Nuon Investigative Site | La Jolla | California | — | — |
| Nuon Investigative Site | Santa Maria | California | — | — |
| Nuon Investigative Site | Washington D.C. | District of Columbia | — | — |
| Nuon Investigative Site | New Port Richey | Florida | — | — |
| Nuon Investigative Site | Honolulu | Hawaii | — | — |
| Nuon Investigative Site | Boise | Idaho | — | — |
| Nuon Investigative Site | Bloomington | Indiana | — | — |
| Nuon Investigative Site | Owensboro | Kentucky | — | — |
| Nuon Investigative Site | Baltimore | Maryland | — | — |
| Nuon Investigative Site | Wheaton | Maryland | — | — |
| Nuon Investigative Site | Billings | Montana | — | — |
| Nuon Investigative Site | Omaha | Nebraska | — | — |
| Nuon Investigative Site | Reno | Nevada | — | — |
| Nuon Investigative Site | Teaneck | New Jersey | — | — |
| Nuon Investigative Site | Durham | North Carolina | — | — |
| Nuon Investigative Site | Cincinnati | Ohio | — | — |
| Nuon Investigative Site | Oklahoma City | Oklahoma | — | — |
| Nuon Investigative Site | Lake Oswego | Oregon | — | — |
| Nuon Investigative Site | Duncansville | Pennsylvania | — | — |
| Nuon Investigative Site | West Reading | Pennsylvania | — | — |
| Nuon Investigative Site | Charleston | South Carolina | — | — |
| Nuon Investigative Site | Greenville | South Carolina | — | — |
| Nuon Investigative Site | Waco | Texas | — | — |
| Nuon Investigative Site | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01109121, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 5, 2011 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01109121 live on ClinicalTrials.gov.